Search
Diabetes Clinical Trials in Mesa, AZ
A listing of 3 Diabetes clinical trials in Mesa, AZ actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 3 of 3
The city of Mesa, Arizona, currently has 3 active clinical trials seeking participants for Diabetes research studies.
Featured Trial
Type 2 Diabetes (Hard-to-Control) Clinical Study
Recruiting
Studying an Investigational Medication for Adults with Hard-to-Control Type 2 Diabetes.
We're reaching out to let you know that a type 2 diabetes study is looking for participants to help advance investigational weight management treatment options.
Participants who qualify and enroll may receive compensation for related time and travel.
We're reaching out to let you know that a type 2 diabetes study is looking for participants to help advance investigational weight management treatment options.
Participants who qualify and enroll may receive compensation for related time and travel.
Conditions:
Type 2 Diabetes (Hard-to-Control)
Diabetes Mellitus
Type 2
Type 2 Diabetes
Diabete Type 2
Featured Trial
Diabetic Pain Study Clinical Study
Recruiting
Do you have diabetes and pain in your lower legs? Clinical trials are running for participants experiencing pain associated with diabetes.
Conditions:
Diabetic Pain Study
Diabetic
Diabetes
Diabetes Mellitus
Type 2
Featured Trial
Obesity w/ CVD or T2DM Clinical Study
Recruiting
We are actively recruiting patients who are interested in participating in an obesity clinical trial. The main purpose of this study is to evaluate the cardiovascular safety of the investigational weight loss medication compared with a placebo in participants who are at an increased risk of adverse cardiovascular outcomes (ie. heart attack and stroke)..
Conditions:
Obesity w/ CVD or T2DM
Obesity
Overweight and Obesity
Morbid Obesity
Obesity
Featured Therapy
Unique Treatment for High Blood Pressure
Worried about high blood pressure? Think beyond typical high blood pressure treatments.
People who may be candidates for this procedure:
• Are at least 18 years old
• Have been unable to manage their high blood pressure with medications or lifestyle changes alone¹
Learn about a safe and effective procedure that may help reduce high blood pressure. See if you qualify today.
¹ Kandzari DE, et al. J Am Coll Cardiol. Nov 7, 2023;82(19):1809-1823.
People who may be candidates for this procedure:
• Are at least 18 years old
• Have been unable to manage their high blood pressure with medications or lifestyle changes alone¹
Learn about a safe and effective procedure that may help reduce high blood pressure. See if you qualify today.
¹ Kandzari DE, et al. J Am Coll Cardiol. Nov 7, 2023;82(19):1809-1823.
Conditions:
High Blood Pressure
High Blood Pressure (& [Essential Hypertension])
High Blood Pressure (Hypertension).
Hypertension
Essential Hypertension
Featured Trial
Heart Failure Risk w/ T2DM Clinical Study
Recruiting
We are actively recruiting for a clinical study aimed at reducing the risk of heart failure events and cardiovascular-related deaths, such as heart attack, stroke, or hospitalization due to worsening heart failure.
Find out if you qualify.
Find out if you qualify.
Conditions:
Heart Failure Risk w/ T2DM
Heart Failure
Congestive Heart Failure
Chronic Heart Failure
Heart Failure
Featured Trial
Now Recruiting: Cardiovascular Disease (CVD) Clinical Studies
Recruiting
We are seeking participants for 31 cardiovascular disease (CVD) studies covering conditions such as high blood pressure (hypertension), atherosclerotic heart disease, high cholesterol (hyperlipidemia), heart failure, and type 2 diabetes with CVD. The studies are recruiting adults ages 18 and older who have been diagnosed with one or more of these conditions and are currently receiving treatment.
See if you qualify today.
See if you qualify today.
Conditions:
CVD Multi
CVD
Cardiovascular Disease
Cardiovascular Diseases
High Blood Pressure
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
Recruiting
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
08/13/2025
Locations: Desert Clinical Research, Mesa, Arizona
Conditions: Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
Recruiting
The purpose of this single-arm interventional study is to evaluate the long-term safety, efficacy, and durability of the Symplicity Spyral system in subjects treated with renal denervation.
Additionally, long-term follow-up data will also be collected from eligible subjects previously treated in the SPYRAL PIVOTAL-SPYRAL HTN-OFF MED and SPYRAL HTN-ON MED studies.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/12/2025
Locations: Banner Heart Hospital, Mesa, Arizona
Conditions: Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
Recruiting
A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes over a 6 months treatment period.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
06/27/2025
Locations: Investigative site, Mesa, Arizona
Conditions: Obesity and Type 2 Diabetes
1 - 3 of 3
